Label-Free Enrichment of Circulating Tumor Cells (CTCs).

Heterogeneity Resolved with Specificity 

Facilitating rapid discovery and development of potentially predictive signatures with the most advanced view of immuno-oncology biology.

The pursuit of a cure has taken a decisive new turn. nCounter SPRINT represents the most affordable product variation of a powerful new technology that is changing the face of cancer research. You can now exploit the benefits of nCounter technology in your research.

Nanostring's patented technology used in the nCounter Analysis System is a true digital detection technology capable of highly multiplexed, direct profiling of individual molecules in a single reaction without amplification. Barcoded probes hybridize directly to a target molecule in solution. The Reporter Probe carries the barcode, and the Capture Probe allows the complex to be immobilized for data collection.

Enabling High-Plex Expression Analysis and Reduces Hands-on Time as Compared to qPCR.

Don’t let sample volume limit your analytical aspirations. Detect DNA, RNA, and protein changes in a single assay to use less precious material and gather more informative data.

Quantify protein and gene expression in one experiment with nCounter® Vantage 3D™ Immune Assays. Our immune assays are designed to complement our 770-plex immune-focused mRNA panel for in-depth characterization of up to 800 total targets:

Complementary companion advanced analysis software for Nanostring nCounter.

Nugen's Ovation RNA-Seq V2

Genomax provides a range of technology solutions in understanding the complexity of transcriptome regulation such RNA sequencing, microarray, digital gene expression and antibody array. 

Genomax provides a range of technology solutions in understanding the complexity of transcriptome regulation such RNA sequencing, microarray, digital gene expression and antibody array.